Edwin Spaans
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
Papers in
-
- Mitochondrial Function and Pathology 2
-
- Pharmacological Effects and Toxicity Studies 2
- Pharmaceutical studies and practices 2
- Co-authors
- Dick Tibboel (4 shared papers)Saskia N. de Wildt (4 shared papers)Janneke N. Samsom (2 shared papers)Miriam G. Mooij (2 shared papers)P. A. M. Peeters (3 shared papers)Ute I. Schwarz (1 shared paper)J. Steven Leeder (1 shared paper)Richard B. Kim (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)European Neuropsychopharmacology (2 papers)European Journal of Clinical Pharmacology (2 papers)Drug Metabolism and Disposition (2 papers)Clinical Pharmacokinetics (2 papers)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Edwin Spaans
16 papers receiving 429 citations
Peers
Comparison fields: 5 of 82
- Pharmacology 105
- Clinical Biochemistry 64
- Pediatrics, Perinatology and Child Health 164
- Psychiatry and Mental health 76
- Pharmacology 76
Countries citing papers authored by Edwin Spaans
This map shows the geographic impact of Edwin Spaans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Spaans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Spaans more than expected).
Fields of papers citing papers by Edwin Spaans
This network shows the impact of papers produced by Edwin Spaans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Spaans. The network helps show where Edwin Spaans may publish in the future.
Co-authors
The 25 scholars most cited alongside Edwin Spaans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 112 | |
| 2 | 2019 | 73 | |
| 3 | 2018 | 46 | |
| 4 | 2017 | 43 | |
| 5 | 2010 | 34 | |
| 6 | 2002 | 34 | |
| 7 | 2014 | 28 | |
| 8 | 2011 | 21 | |
| 9 | 2018 | 12 | |
| 10 | 2008 | 8 | |
| 11 | 2012 | 7 | |
| 12 | 2019 | 6 | |
| 13 | 2012 | 6 | |
| 14 | 2019 | 3 | |
| 15 | 2003 | 2 | |
| 16 | 2010 | 2 |
About Edwin Spaans
Edwin Spaans is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health, Oncology and Pharmacology, having authored 16 papers that have together received 437 indexed citations. Recurring topics across this work include Epilepsy research and treatment (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Schizophrenia research and treatment (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Pharmaceutical studies and practices (2 papers), Mitochondrial Function and Pathology (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Pharmacology (105 citations), Clinical Biochemistry (64 citations), Pediatrics, Perinatology and Child Health (164 citations), Psychiatry and Mental health (76 citations) and Pharmacology (76 citations). Edwin Spaans has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Dick Tibboel, Saskia N. de Wildt, Janneke N. Samsom, Miriam G. Mooij, P. A. M. Peeters, Ute I. Schwarz, J. Steven Leeder, Richard B. Kim, Jan Smeıtınk and Roger Gaedigk. Their work appears in journals such as Clinical Pharmacology & Therapeutics, European Neuropsychopharmacology, European Journal of Clinical Pharmacology, Drug Metabolism and Disposition and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.